Jeremy Langsam

Investments made by our team (investments I led from intro through closing*) - Biotech: ARase Tx, Clostrabio, CrossBridge Bio, Dimension Inx, Grove Bio, Iterion Tx*, March Bio, Moonlight Tx, Pelagos Pharma, ReAx Bio, RNAv8 Bio, Syntax Bio, Syntis Bio, Vincere, Vivtex - Medtech: Rhaeos, Cardiosense, Synaptrix* - In-kind Investments: Alnair Tx, Inomagen Tx*, CTRL Tx, NovaScan, CiRC Bio* Responsible for deal sourcing, diligence, expert interviews, memos, pitching to IC, closing, and portfolio support (including board observer role for Synaptrix). Led diligence on over 150 companies. Helped with syndication across portfolio and with follow-on investments.

Investments made by our team (investments I led from intro through closing*) - Biotech: ARase Tx, Clostrabio, CrossBridge Bio, Dimension Inx, Grove Bio, Iterion Tx*, March Bio, Moonlight Tx, Pelagos Pharma, ReAx Bio, RNAv8 Bio, Syntax Bio, Syntis Bio, Vincere, Vivtex - Medtech: Rhaeos, Cardiosense, Synaptrix* - In-kind Investments: Alnair Tx, Inomagen Tx*, CTRL Tx, NovaScan, CiRC Bio* Responsible for deal sourcing, diligence, expert interviews, memos, pitching to IC, closing, and portfolio support (including board observer role for Synaptrix). Led diligence on over 150 companies. Helped with syndication across portfolio and with follow-on investments.

Performed due diligence and technical analysis on life science companies and packaged outputs into executive-level presentations that demonstrated value and investment attractiveness Analyzed technological and strategic roadmaps while investigating business case for investments Interviewed medical industry experts to inform diligence process and innovation radar Powerpoint presentation development of pipeline and portfolio highlights for fundraising and potential sponsorships Conducted metadata analysis and wrote clinical white paper report on diagnostics for assessing shunt failure for medical technology portfolio company Rhaeos

Design Infrastructure for data collection for NSF mid-south hub and develop metrics for analysis to answer key strategic questions

Undergraduate Researcher in Merryman Lab Investigated Pulmonary Arterial Hypertension with murine models in search of potential drug targets for treatment Cultured cells, prepared solutions, and provided general lab and procedural assistance

Researched and published bioinformatics models and algorithms for haploid assembly to better understand applicable elements Learned and familiarized in variety of coding languages for designing own algorithm Shared findings with team and combine knowledge for effective research and understanding variety of sorting algorithms Utilized Vanderbilt Advanced Computer Center for Research and Education (ACCRE) to expedite computing speed and power

Effectively adapted inventory and business needs and customer experience to pandemic fluctuations Helped develop and balance needs, risks and costs of opening small business during pandemic